Cleared Traditional

K070238 - AMPLATZER RELIANT CATHETER DELIVERY SYSTEM

K070238 is an FDA 510(k) clearance for AMPLATZER RELIANT CATHETER DELIVERY SYSTEM, manufactured by Aga Medical Corp.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 34-day FDA review.

K070238 · Aga Medical Corp. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Feb 2007
Decision
34d
Days
Class 2
Risk

K070238 is an FDA 510(k) clearance for the AMPLATZER RELIANT CATHETER DELIVERY SYSTEM. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Aga Medical Corp. (Plymouth, US). The FDA issued a Cleared decision on February 28, 2007 after a review of 34 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K070238

510(k) Number K070238 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 25, 2007
Decision Date February 28, 2007
Days to Decision 34 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
91d faster than avg
Panel avg: 125d · This submission: 34d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DQY Catheter, Percutaneous

All 861
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K070238.
GOPHER 2F SUPPORT CATHETER, MODEL 5600 AND GOPHER 3F SUPPORT CATHETER, MODEL 5610
K070372 · Vascular Solutions, Inc. · Jun 2007
MODIFICATION TO PROXIS SYSTEM, MODEL EPS 101
K063638 · St Jude Medical · May 2007
ACUMEN INSIGHT ENDOCARDIAL VISUALIZATION SYSTEM
K070051 · Acumen Medical, Inc. · Apr 2007
THE CROSSER CATHETER, MODEL CR1100 AND SYSTEM ELECTRONICS, MODEL FG1002-02
K062868 · Flowcardia, Inc. · Jan 2007
ATRIUM MEDICAL CORPORATION CLEARWAY RX CATHETER
K061680 · Atrium Medical Corp. · Dec 2006
ASAHI PRECIOUS GUIDE CATHETER
K061601 · Asahi Intecc Co., Ltd. · Nov 2006
K070238 · AMPLATZER RELIANT CATHETER DELIVERY SYSTEM
Download PDF FDA Summary Aga Medical Corp.